• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON ENDO-SURGERY, LLC. PROXIMATE*HCS HEMORR CIR STAPL; STAPLE, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON ENDO-SURGERY, LLC. PROXIMATE*HCS HEMORR CIR STAPL; STAPLE, IMPLANTABLE Back to Search Results
Catalog Number PPH01
Health Effect - Clinical Codes Incontinence (1928); Pain (1994); Blood Loss (2597); No Code Available (3191)
Date of Event 01/01/2005
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).Date of event: publication year of 2005.Batch # unk.This report is related to a journal article; therefore, no product will be returned for analysis and the manufacturing records cannot be reviewed as the lot/batch number has not been provided.(b)(4).
 
Event or Problem Description
Title: prospective randomised clinical trial of single versus double purse-string stapled mucosectomy in the treatment of prolapsed haemorrhoids.Authors: francisco pérez-vicente, antonio arroyo, pilar serrano, fernando candela, ana sanchez and rafael calpena.Citation: int j colorectal dis (2006) 21: 38¿43; doi 10.1007/s00384-004-0720-3; published online: 21 april 2005.This prospective randomized clinical trial aimed to compare the outcomes after single purse-string csm versus double purse-string csm.Between may 2000 and june 2002, one hundred consecutive patients (male n=63, female n=37, mean age 50.70 years) were randomized to single purse-string csm (group 1, n=50, male n=34, female n=16, with mean age 49.50 years) versus double purse-string csm (group 2, n=50, male n=29, female n=21, with mean age 51.92 years.The operation was carried out according to the technique initially described by longo utilizing a 33-mm circular stapling device (pph 33-01, ethicon endosurgery).Complications in the single purse group included anastomotic bleeding requiring transfixive suture (n=14), staple suture defect (n=2), pain on defecation (n=14), frequent bleeding postoperative (n=7), daily bleeding postoperative (n=2) in which one patient was taken back to the operating theatre within the first 12 postoperative hours; incontinence (n=7) which spontaneously reversed with no treatment, persistent pain (n=3) in which one patient had removal of several staples that were too close to the dentate line and residual prolapse/recurrence (n=2) in which one patient underwent another csm and the other patient underwent a milligan ¿ morgan procedure.In the double purse group, complications included anastomotic bleeding requiring transfixive suture (n=23), staple suture defect (n=1), pain on defecation (n=9), frequent bleeding postoperative (n=7) and incontinence (n=5) which spontaneously reversed with no treatment.In conclusion, double purse-string csm resects a greater doughnut and increases the distance of the staple suture from the dentate line in comparison to single purse-string csm, improving results in terms of early postoperative pain.Larger series should be necessary to assert whether recurrence is lower.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Common Device Name
STAPLE, IMPLANTABLE
Manufacturer (Section D)
ETHICON ENDO-SURGERY, LLC.
475 calle c
guaynabo 00969
MDR Report Key8843568
Report Number3005075853-2019-20903
Device Sequence Number19354964
Product Code GDW
UDI-Device Identifier10705036012993
UDI-Public10705036012993
Combination Product (Y/N)N
PMA/510(K) Number
K030925
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,literature
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 07/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberPPH01
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 07/11/2019
Initial Report FDA Received Date07/30/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-